Announcements Trials
Browse Landscape

Status

Recruiting 15Completed 13Unknown 8Terminated 3Not yet recruiting 3Active not recruiting 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 22Observational 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 141Neoplasms 132Prostatic Neoplasms 80Carcinoma, Non-Small-Cell Lung 80Lung Neoplasms 67Colorectal Neoplasms 47Carcinoma, Hepatocellular 37Stomach Neoplasms 32Multiple Myeloma 29Brain Neoplasms 28Uterine Cervical Neoplasms 27Pancreatic Neoplasms 26Ovarian Neoplasms 26Melanoma 25Head and Neck Neoplasms 25Rectal Neoplasms 24Colonic Neoplasms 24Urinary Bladder Neoplasms 22Neoplasm Metastasis 21Hematologic Neoplasms 21Carcinoma, Renal Cell 20Leukemia, Myeloid, Acute 19Esophageal Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Endometrial Neoplasms 17Recurrence 15Lymphoma 15Liver Neoplasms 15Cardiovascular Diseases 15COVID-19 15

Interventions

BCG Vaccine 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Non-Muscle Invasive Bladder Neoplasms × Clear all
NCT03933826 2026-05-12

CISTO

University of Washington

Active not recruiting
570 enrolled 27 charts
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Neoplasms by Site, Recurrence, Urogenital Neoplasms, Urologic Diseases

NCT05981131 2026-04-29

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

ImmunityBio, Inc.

Active not recruiting
6 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT07511517 2026-04-09

BladMetrix

Oslo University Hospital

Active not recruiting
500 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡